{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:46:31Z","timestamp":1778291191441,"version":"3.51.4"},"reference-count":75,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Faculty of Martin Luther University Halle-Wittenberg"},{"name":"German Research Foundation (DFG)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The chemotherapeutic agent vincristine is commonly used for a variety of hematologic cancers, as well as solid tumors of the head and neck, bronchial carcinoma, as part of the procarbazine, lomustine and vincristine (PCV) regimen, for glioma. Damage to nerve tissue (neuropathy) is often dose-limiting and restricts treatment. Nimodipine is a calcium antagonist that has also shown neuroprotective properties in preliminary studies. In this approach here, we investigated the effects of the combination of vincristine and nimodipine on three cancer cell lines (A549, SAS and LN229) and neuronal cells (RN33B, SW10). Fluorescence microscopy, lactate dehydrogenase (LDH) assays and Western blot analyses were used. Nimodipine was able to enhance the cell death effects of vincristine in all tumor cells, while neuronal cells were protected and showed less cell death. There was an opposite change in the protein levels of Ak strain transforming\/protein kinase B (AKT) in tumor cells (down) and neuronal cells (up), with simultaneous increased protein levels of cyclic adenosine monophosphate response element-binding protein (CREB) in all cell lines. In the future, this approach may improve tumor response to chemotherapy and reduce unwanted side effects such as neuropathy.<\/jats:p>","DOI":"10.3390\/ijms251910389","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:10:27Z","timestamp":1727417427000},"page":"10389","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nimodipine Used with Vincristine: Protects Schwann Cells and Neuronal Cells from Vincristine-Induced Cell Death but Increases Tumor Cell Susceptibility"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3149-0797","authenticated-orcid":false,"given":"Maximilian","family":"Scheer","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Polak","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Fritzsche","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Strauss","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-1487","authenticated-orcid":false,"given":"Christian","family":"Scheller","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4581-5185","authenticated-orcid":false,"given":"Sandra","family":"Leisz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-1-4831-9929-0.50010-3","article-title":"The Vinca Alkaloids","volume":"12","author":"Neuss","year":"1964","journal-title":"Adv. Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gupta, S., Chaudhary, K., Kumar, R., Gautam, A., Nanda, J.S., Dhanda, S.K., Brahmachari, S.K., and Raghava, G.P.S. (2016). Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine. Sci. Rep., 6.","DOI":"10.1038\/srep23857"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/aps.2012.44","article-title":"Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors","volume":"33","author":"Yan","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10555-010-9259-7","article-title":"Induction chemotherapy response and recurrence rates in correlation with N0 or N+ stage in oral squamous cell cancer (OSCC)","volume":"29","author":"Olasz","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.annonc.a058906","article-title":"Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group","volume":"5","author":"Clavel","year":"1994","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biopha.2017.10.041","article-title":"New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer","volume":"96","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sampson, J., Ju, H.-M., Song, J.-Y., Fry, A.M., Bayliss, R., and Choi, J. (2022). A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC. Cancers, 14.","DOI":"10.3390\/cancers14030779"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2217\/nnm-2020-0169","article-title":"Optimization and efficacy study of synergistic vincristine coloaded liposomal doxorubicin against breast and lung cancer","volume":"15","author":"Ghosh","year":"2020","journal-title":"Nanomedicine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMoa1500925","article-title":"Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma","volume":"374","author":"Buckner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1212\/01.wnl.0000197792.73656.c2","article-title":"PCV chemotherapy for recurrent glioblastoma","volume":"66","author":"Schmidt","year":"2006","journal-title":"Neurology"},{"key":"ref_11","first-page":"1529","article-title":"Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide","volume":"18","author":"Wick","year":"2016","journal-title":"Neuro Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cpt.1209","article-title":"Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy: Progress Continues","volume":"105","author":"Diouf","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","article-title":"Aspects of vincristine-induced neuropathy in hematologic malignancies: A systematic review","volume":"84","author":"Madsen","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e26677","DOI":"10.1002\/pbc.26677","article-title":"Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement","volume":"64","author":"Nazir","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e20210286","DOI":"10.1084\/jem.20210286","article-title":"Immune-mediated vincristine-induced neuropathy: Unlocking therapies","volume":"218","author":"Savelieff","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13346-023-01389-6","article-title":"Vincristine-based nanoformulations: A preclinical and clinical studies overview","volume":"14","author":"Shukla","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jns.12114","article-title":"Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"20","author":"Li","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Triarico, S., Romano, A., Attin\u00e0, G., Capozza, M.A., Maurizi, P., Mastrangelo, S., and Ruggiero, A. (2021). Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084112"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/2347-5625.170977","article-title":"New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy","volume":"3","author":"Schloss","year":"2016","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s11064-011-0701-1","article-title":"Drug resistance in glioblastoma: A mini review","volume":"37","author":"Haar","year":"2012","journal-title":"Neurochem. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5416923","DOI":"10.1155\/2018\/5416923","article-title":"Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Delou, J.M.A., Souza, A.S.O., Souza, L.C.M., and Borges, H.L. (2019). Highlights in Resistance Mechanism Pathways for Combination Therapy. Cells, 8.","DOI":"10.3390\/cells8091013"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1570159X17666190927113021","article-title":"Nimodipine Reappraised: An Old Drug With a Future","volume":"18","author":"Carlson","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/STROKEAHA.119.025997","article-title":"Treatment of Spontaneous Subarachnoid Hemorrhage: Guidelines and Gaps","volume":"51","author":"Maher","year":"2020","journal-title":"Stroke"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Leisz, S., Simmermacher, S., Prell, J., Strauss, C., and Scheller, C. (2019). Nimodipine-Dependent Protection of Schwann Cells, Astrocytes and Neuronal Cells from Osmotic, Oxidative and Heat Stress Is Associated with the Activation of AKT and CREB. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184578"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s10143-020-01368-2","article-title":"Prophylactic nimodipine treatment improves hearing outcome after vestibular schwannoma surgery in men: A subgroup analysis of a randomized multicenter phase III trial","volume":"44","author":"Scheller","year":"2021","journal-title":"Neurosurg. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejpb.2020.03.021","article-title":"Electrospun Nimodipine-loaded fibers for nerve regeneration: Development and in vitro performance","volume":"151","author":"Zech","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fritzsche, S., Strauss, C., Scheller, C., and Leisz, S. (2022). Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105780"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Nurgali, K., Jagoe, R.T., and Abalo, R. (2018). Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00245"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"van den Boogaard, W.M.C., Komninos, D.S.J., and Vermeij, W.P. (2022). Chemotherapy Side-Effects: Not All DNA Damage Is Equal. Cancers, 14.","DOI":"10.3390\/cancers14030627"},{"key":"ref_31","first-page":"6731","article-title":"Vincristine-induced blindness: A case report and review of literature","volume":"34","author":"Adhikari","year":"2014","journal-title":"Anticancer. Res."},{"key":"ref_32","first-page":"410","article-title":"Glutamate ameliorates experimental vincristine neuropathy","volume":"279","author":"Boyle","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2017.11.011","article-title":"Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth","volume":"111","author":"Kater","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/molecules20011003","article-title":"Neuroprotective and neuroregenerative effects of nimodipine in a model system of neuronal differentiation and neurite outgrowth","volume":"20","author":"Bork","year":"2015","journal-title":"Molecules"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0303-8467(99)00061-X","article-title":"The effects of anticancer drugs in combination with nimodipine and verapamil on cultured cells of glioblastoma multiforme","volume":"101","author":"Durmaz","year":"1999","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3171\/jns.1994.81.4.0587","article-title":"Reversal of chemoresistance in malignant gliomas by calcium antagonists: Correlation with the expression of multidrug-resistant p-glycoprotein","volume":"81","author":"Kiwit","year":"1994","journal-title":"J. Neurosurg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-0404.1989.tb03731.x","article-title":"Inhibitory effect of calcium channel blockers on proliferation of human glioma cells in vitro","volume":"79","author":"Stepien","year":"1989","journal-title":"Acta Neurol. Scand."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s11033-019-04706-w","article-title":"Vincristine combination with Ca+2 channel blocker increase antitumor effects","volume":"46","author":"Taghizadehghalehjoughi","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00132307","article-title":"Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine","volume":"2","author":"Honn","year":"1984","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2016.11.053","article-title":"Autophagy and Akt\/CREB signalling play an important role in the neuroprotective effect of nimodipine in a rat model of vascular dementia","volume":"325(Pt A)","author":"Hu","year":"2017","journal-title":"Behav. Brain Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuro.2020.10.001","article-title":"Quercetin provides protection against the peripheral nerve damage caused by vincristine in rats by suppressing caspase 3, NF-\u03baB, ATF-6 pathways and activating Nrf2, Akt pathways","volume":"81","author":"Yardim","year":"2020","journal-title":"Neurotoxicology"},{"key":"ref_42","first-page":"51","article-title":"Nimodipine promotes neurite outgrowth and protects against neurotoxicity in PC12 cells","volume":"24","author":"Kusakabe","year":"2021","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Connelly, J.A., Zhang, X., Chen, Y., Chao, Y., Shi, Y., Jacob, T.C., and Wang, Q.J. (2023). Protein kinase D2 confers neuroprotection by promoting AKT and CREB activation in ischemic stroke. Neurobiol. Dis., 187.","DOI":"10.1016\/j.nbd.2023.106305"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"171037","DOI":"10.1016\/j.peptides.2023.171037","article-title":"Prolactin-induced neuroprotection against excitotoxicity is mediated via PI3K\/AKT and GSK3\u03b2\/NF-\u03baB in primary cultures of hippocampal neurons","volume":"166","author":"Langley","year":"2023","journal-title":"Peptides"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","article-title":"The relation between PI3K\/AKT signalling pathway and cancer","volume":"698","author":"Noorolyai","year":"2019","journal-title":"Gene"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/13543784.2019.1676726","article-title":"Targeting AKT for cancer therapy","volume":"28","author":"Shariati","year":"2019","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13568-020-01082-8","article-title":"MicroRNA-1179 suppresses the proliferation and enhances vincristine sensitivity of oral cancer cells via induction of apoptosis and modulation of MEK\/ERK and PI3K\/AKT signalling pathways","volume":"10","author":"Gao","year":"2020","journal-title":"AMB Express"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/neuonc\/nou058","article-title":"Role of AKT signaling in DNA repair and clinical response to cancer therapy","volume":"16","author":"Liu","year":"2014","journal-title":"Neuro Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/1574892816666210806154225","article-title":"Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K\/AKT Signaling Pathway","volume":"17","author":"Wang","year":"2022","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1158\/1078-0432.CCR-21-1943","article-title":"Activation of PI3K\/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer","volume":"28","author":"Jin","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41419-022-04727-7","article-title":"TRIM46 activates AKT\/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells","volume":"13","author":"Tantai","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.lfs.2015.07.022","article-title":"Erythropoietin protects neuroblastoma cells against etoposide and vincristine by activating ERK and AKT pathways but has no effect in kidney cells","volume":"137","author":"Aguilar","year":"2015","journal-title":"Life Sci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Deng, J., Bai, X., Feng, X., Ni, J., Beretov, J., Graham, P., and Li, Y. (2019). Inhibition of PI3K\/Akt\/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5824-9"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-019-1251-7","article-title":"Ivermectin reverses the drug resistance in cancer cells through EGFR\/ERK\/Akt\/NF-\u03baB pathway","volume":"38","author":"Jiang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","article-title":"Excitotoxicity and stroke: Identifying novel targets for neuroprotection","volume":"115","author":"Lai","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"12317","DOI":"10.1073\/pnas.1007088107","article-title":"NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection","volume":"107","author":"Volakakis","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/fcp.12827","article-title":"Enhancement of nerve regeneration with nimodipine treatment after sciatic nerve injury","volume":"37","author":"Panahi","year":"2023","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10571-014-0110-5","article-title":"Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex","volume":"35","author":"Matsui","year":"2015","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.07080.x","article-title":"CREB: A multifaceted regulator of neuronal plasticity and protection","volume":"116","author":"Sakamoto","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Sapio, L., Salzillo, A., Ragone, A., Illiano, M., Spina, A., and Naviglio, S. (2020). Targeting CREB in Cancer Therapy: A Key Candidate or One of Many? An Update. Cancers, 12.","DOI":"10.3390\/cancers12113166"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-08-1137","article-title":"CREB in the pathophysiology of cancer: Implications for targeting transcription factors for cancer therapy","volume":"15","author":"Sakamoto","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tcb.2005.07.007","article-title":"CREB: The unindicted cancer co-conspirator","volume":"15","author":"Conkright","year":"2005","journal-title":"Trends Cell Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.anndiagpath.2015.06.010","article-title":"Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma","volume":"19","author":"Chang","year":"2015","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1615\/CritRevOncog.v16.i1-2.50","article-title":"CREB and leukemogenesis","volume":"16","author":"Cho","year":"2011","journal-title":"Crit. Rev. Oncog."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1038\/sj.onc.1210465","article-title":"The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells","volume":"26","author":"Wang","year":"2007","journal-title":"Oncogene"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1073\/pnas.0502990102","article-title":"Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer","volume":"102","author":"Sum","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","first-page":"6534","article-title":"LMO4 promotes the invasion and proliferation of gastric cancer by activating PI3K-Akt-mTOR signaling","volume":"11","author":"Wang","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.21037\/jtd.2016.12.22","article-title":"LMO4 is a prognostic marker involved in cell migration and invasion in non-small-cell lung cancer","volume":"8","author":"Wang","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ruiz-Aparicio, P.F., Uribe, G.I., Linares-Ballesteros, A., and Vernot, J.-P. (2021). Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-\u03baB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity. Molecules, 26.","DOI":"10.3390\/molecules26175366"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2021.08.004","article-title":"JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition","volume":"148","author":"Luo","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Owen, K.L., Brockwell, N.K., and Parker, B.S. (2019). JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression. Cancers, 11.","DOI":"10.3390\/cancers11122002"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Hoya, A., and Soto-Cruz, I. (2020). Role of the JAK\/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6\/E7 Oncoproteins. Cells, 9.","DOI":"10.3390\/cells9102297"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.2174\/0929867328666201207202012","article-title":"Targeting the JAK\/STAT Signaling Pathway for Breast Cancer","volume":"28","author":"Shao","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in Cancer Immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","article-title":"The potential and controversy of targeting STAT family members in cancer","volume":"60","author":"Verhoeven","year":"2020","journal-title":"Semin. Cancer Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/19\/10389\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:04:46Z","timestamp":1760112286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/19\/10389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":75,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["ijms251910389"],"URL":"https:\/\/doi.org\/10.3390\/ijms251910389","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}